# Clinical trials recruiting in Brazil: 1,357 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,357 trials recruiting or not yet recruiting with a site in Brazil, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Brazil: 1,357 rows for $67.85, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 34 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/brazil

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,357
- Recruiting or not yet: 1,357
- Read on: November 19, 2026

## Trials

The 25 newest of 1,357, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944794 | Safety and Effectiveness of Different Interface Models for Non-invasive Ventilation Support for Preterm Newborns With a Gestational Age... | University of Sao Paulo General Hospital | Not applicable | Recruiting | Respiratory Distress Syndrome in Premature Infants, Non Invasive Ventilation (NIV), Nasal Injury | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944794) |
| November 17, 2026 | NCT07942571 | Olfactory Function in Patients With Sinonasal Diseases: A Multicenter Observational Study | University of Brasilia | Observational | Recruiting | Chronic Rhinosinusitis, Sinonasal Diseases, Olfactory Dysfunction | 3,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942571) |
| November 17, 2026 | NCT07941804 | Telehealth Stepped Care for Child and Adolescent Mental Health | Child Mind Institute | Not applicable | Not yet recruiting | Anxiety, Depression Symptom, Disruptive Behaviors, Child and Adolescent Mental Health | 4,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941804) |
| November 17, 2026 | NCT07941648 | Combined Treatments for Somatosensory Tinnitus | Universidade Federal de Santa Maria | Not applicable | Recruiting | Somatosensory Tinnitus | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941648) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 16, 2026 | NCT07939620 | Non-inferiority Study of a Hydroxyapatite and Calcium Hypophosphite Toothpaste Compared With Two Comparator Toothpastes in Dentin... | Dr. August Wolff GmbH & Co. KG Arzneimittel | Not applicable | Recruiting | Dentin Hypersensitivity | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939620) |
| November 13, 2026 | NCT07934446 | High-Frequency Ultrasound Monitoring of Cutaneous Leishmaniasis During Treatment | University of Brasilia | Observational | Recruiting | Cutaneous Leishmaniasis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934446) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07931040 | Virtual Reality for Motor and Cognitive Function in People With Parkinson's Disease | Universidade Metodista de Piracicaba | Not applicable | Recruiting | PARKINSON DIS | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931040) |
| November 10, 2026 | NCT07928193 | Sac-TMT in Salivary Gland Cancers | Latin American Cooperative Oncology Group | Phase 2 | Not yet recruiting | Salivary Gland Cancers, Adenoid Cystic Carcinoma of the Salivary Gland | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928193) |
| November 9, 2026 | NCT07925762 | Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression | University of Sao Paulo | Not applicable | Recruiting | Postpartum Depression, Depression, Postpartum | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925762) |
| November 6, 2026 | NCT07922265 | Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI) | Universidade Federal do Paraná | Not applicable | Not yet recruiting | Healthy Volunteers - Male and Female | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922265) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 5, 2026 | NCT07918560 | Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and Psoriasis | Brainfarma Industria Química e Farmacêutica S/A | Not applicable | Not yet recruiting | Atopic Dermatitis, Psoriasis | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918560) |
| November 5, 2026 | NCT07918040 | Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions | Sponsor not shown (see the record) | Phase 4 | Recruiting | Hematologic Test, Agranulocytosis, Side Effects, Blood Pressure Monitoring, Hepatic Complications, Renal Effects | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918040) |
| November 4, 2026 | NCT07917728 | Smartphone Enabled Detection of Cognitive Motor Dissociation in the ICU | Columbia University | Observational | Recruiting | Traumatic Brain Injury (TBI) Patients, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Cardiac Arrest (CA) | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917728) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07911865 | Acute Effect of Aerobic Exercise on Cardiovascular Reactivity During a Mental Stress Test in Teachers | Federal University of Mato Grosso | Not applicable | Not yet recruiting | Behavior | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911865) |
| November 2, 2026 | NCT07910747 | Effects of Taurine Supplementation and Morning or Evening High-intensity Exercise on Circadian Clock Genes and Inflammatory Parameters in... | University of Sao Paulo | Not applicable | Not yet recruiting | Obesity (Disorder), Inflammation | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910747) |
| November 2, 2026 | NCT07908953 | Prospective Evaluation of Recombinant Pbserum Plus® and Pbserum HA 2.0® in Aesthetic and Regenerative Bioremodeling | Antony Barbosa Institute | Not applicable | Not yet recruiting | Skin Laxity, Localized Adiposity, Cellulite, Tissue Fibrosis, Pathological Scarring | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908953) |
| October 29, 2026 | NCT07903532 | Multicenter Study for External Validation of the TB-NET Score | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Observational | Recruiting | Tumor Burden, Neuroendocrine (NE) Tumors | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903532) |
| October 29, 2026 | NCT07903441 | Multiple Interventions With Distinct Anti-reservoir Activities in People on Antiretroviral Treatment | Federal University of São Paulo | Phase 2 | Recruiting | HIV - Human Immunodeficiency Virus | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903441) |
| October 28, 2026 | NCT07901621 | Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b | University of Brasilia | Not applicable | Not yet recruiting | Chronic Kidney Disease Stage 3A, Chronic Kidney Disease Stage 3B, Chronic Kidney Disease, Non-dialysis | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901621) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Hospital de Clinicas de Porto Alegre | Porto Alegre | 47 |
| Hospital de Clínicas de Porto Alegre | Porto Alegre | 43 |
| Hospital Moinhos de Vento | Porto Alegre | 41 |
| Hospital Israelita Albert Einstein | São Paulo | 29 |
| Fundação Pio XII - Hospital de Câncer de Barretos | Barretos | 26 |
| Hospital Erasto Gaertner | Curitiba | 24 |
| Hospital São Lucas da PUCRS | Porto Alegre | 23 |
| Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein | São Paulo | 21 |
| Hospital Alemao Oswaldo Cruz | São Paulo | 18 |
| Hospital Nossa Senhora da Conceição | Porto Alegre | 16 |
| Instituto Nacional de Câncer - INCA | Rio de Janeiro | 15 |
| Ruschel Medicina e Pesquisa Clínica | Rio de Janeiro | 15 |
| Icesp - Instituto Do Câncer Do Estado de São Paulo | São Paulo | 14 |
| IBCC - Núcleo de Pesquisa e Ensino | São Paulo | 14 |
| Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo | São Paulo | 13 |
| Liga Norte Riograndense Contra O Cancer | Natal | 13 |
| Hospital Felicio Rocho | Belo Horizonte | 11 |
| Instituto de Pesquisa clinica de Campinas | Campinas | 11 |
| Instituto de Oncologia Saint Gallen | Santa Cruz do Sul | 11 |
| Hospital Paulistano | São Paulo | 11 |
| AC Camargo Cancer Center | São Paulo | 11 |
| Liga Norte Riograndense Contra o Cancer | Natal | 10 |
| Hospital Brasilia | Brasília | 10 |
| Hospital de Clínicas de Passo Fundo | Passo Fundo | 10 |
| Hospital Ernesto Dornelles | Porto Alegre | 10 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 6 |
| Phase 1 | 33 |
| Phase 1/2 | 60 |
| Phase 2 | 141 |
| Phase 2/3 | 40 |
| Phase 3 | 434 |
| Phase 4 | 51 |
| Not applicable | 408 |
| Observational | 184 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 48 |
| Breast Neoplasms | 39 |
| Obesity | 35 |
| Heart Failure | 33 |
| Diabetes Mellitus, Type 2 | 32 |
| Neoplasms | 32 |
| Hypertension | 25 |
| Overweight | 23 |
| Stroke | 23 |
| Motor Activity | 23 |
| Inflammation | 21 |
| Multiple Myeloma | 21 |
| Lung Neoplasms | 20 |
| Neoplasm Metastasis | 20 |
| Cardiovascular Diseases | 19 |
| Pulmonary Disease, Chronic Obstructive | 19 |
| Renal Insufficiency, Chronic | 18 |
| Prostatic Neoplasms | 17 |
| Colorectal Neoplasms | 17 |
| Coronary Artery Disease | 17 |
| Recurrence | 16 |
| Lupus Erythematosus, Systemic | 16 |
| Crohn Disease | 15 |
| Sleep Initiation and Maintenance Disorders | 14 |
| Parkinson Disease | 14 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 81 |
| University of Sao Paulo | 65 |
| University of Sao Paulo General Hospital | 63 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 49 |
| Hospital de Clinicas de Porto Alegre | 42 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 33 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 32 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 32 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 26 |
| University of Nove de Julho | 25 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 23 |
| Hospital Israelita Albert Einstein | 22 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 21 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 17 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 15 |
| [BeOne Medicines](https://specstream.ai/data/clinical-trials/company/beone-medicines) | 15 |
| Federal University of Minas Gerais | 14 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 14 |
| Universidade Federal de Pernambuco | 14 |
| Federal University of São Paulo | 13 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 12 |
| Instituto do Cancer do Estado de São Paulo | 12 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 12 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 11 |
| Universidade Federal Fluminense | 11 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [B2B quarry companies in the United States](https://specstream.ai/data/businesses/b2b-quarry-companies/united-states)
- [Packing supply stores in the United States](https://specstream.ai/data/businesses/packing-supply-stores/united-states)
- [Cosmetology schools in the United States](https://specstream.ai/data/businesses/cosmetology-schools/united-states)
- [Shipping collection companies in the United States](https://specstream.ai/data/businesses/shipping-collection-companies/united-states)
- [French restaurants in the United States](https://specstream.ai/data/businesses/french-restaurants/united-states)
